Related Experiment Video
Updated: Jul 7, 2026

Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
Can early-onset nonoliguric hyperkalemia be predicted in extremely premature infants?
Sudhin Thayyil1, Stephen Terence Kempley, Ajay Sinha
1Department of Cardiovascular Imaging, Great Ormond Street Hospital UCL Institute of Child Health, London, UK. s.thayyil@ich.ucl.ac.uk
Abstract:
Hyperkalemia is common soon after birth in extremely premature infants and often occurs in the absence of oliguria or renal failure. Our objective was to examine the early biochemical indicators, clinical risk factors, and incidence of early-onset nonoliguric hyperkalemia in a cohort of extremely premature infants. We studied clinical and biochemical data from 154 consecutive premature infants < or = 28 weeks of gestation admitted to a tertiary neonatal unit over a 3-year period. Hyperkalemia (> 7 mmol/L) was found in 33 (21%) of patients during the first 4 days of life, with peak potassium levels occurring at 3 days of age. Hyperkalemic patients had similar birthweight, gestation, creatinine and sodium levels as normokalemic infants, but they had higher phosphate and urea levels, with lower calcium levels. The combination of a high phosphate (> 2.0 mmol/L) and a high potassium (> 5.6 mmol/L) within 6 hours of birth predicted later development of hyperkalemia, with a positive likelihood ratio of 8.3 (post-test probability, 70%). Potassium level of < 5.6 mmol/L at birth indicates subsequent hyperkalemia is unlikely (likelihood ratio, 0.25; post-test probability, 4%). Mildly elevated potassium and phosphate levels within 6 hours after birth may be useful in predicting the development of early-onset hyperkalemia.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Antihypertensive Drugs: Potassium-Sparing Diuretics
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

